Exploring Dose-Response in Incretin and Multi-Agonist Obesity Treatments | Retatrutide News

The study analyzes dose-response profiles in obesity drugs, focusing on incretin and multi-agonists. It aims to optimize GLP-1 receptor agonists, includ...
Clinical Trials · October 21, 2026